查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1717064

2025年肝病診斷全球市場報告

Liver Disease Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年肝病診斷市場規模將強勁成長。到 2029 年，這一數字將成長至 520.4 億美元，年複合成長率（CAGR）為 7.4%。預測期內預期的成長動力包括老年人口增加、研發支出增加、切片檢查程序和相關疾病數量增加以及遠端醫療的廣泛應用等因素。預計這段時期的主要趨勢包括個人化醫療的興起、診斷套件的技術進步、快速檢測的創新、醫療保健技術的進步以及診斷方法的改進。

預計酒精消費量的增加將推動肝病診斷市場的成長。由於社會規範的變化、酒精價格和供應的增加以及壓力和心理健康挑戰的增加，酒精消費量正在增加。飲酒會影響肝臟健康，因此檢測脂肪肝、肝炎和肝硬化等肝損傷早期徵兆的診斷工具至關重要。例如，根據英國國家醫療服務體系 (NHS) 2022 年 12 月的數據，酒精消費量隨著年齡的成長而增加，62% 的 16 至 24 歲人群報告在過去 12 個月內飲酒，85% 的 55 至 74 歲人群飲酒。由於對肝臟健康的早期檢測和監測的需求日益增加，這一趨勢促進了肝病診斷市場的成長。

肝病診斷市場的公司正專注於開發創新的非侵入性工具來評估肝臟狀況。這些工具提供了準確、有效的診斷方法，無需切片檢查等侵入性手術。例如，2024年9月，印度診斷中心City Imaging & Clinical推出了FibroScan，這是一款非侵入性診斷工具，旨在早期發現非酒精性脂肪肝病（NAFLD）和酒精性肝病（ALD）等肝病。 FibroScan 使用彈性成像技術快速且準確地測量肝臟硬度和脂肪含量，為傳統切片檢查提供了一種非侵入性的替代方法。該過程僅需 5 到 15 分鐘，包括將探針放入肝臟並發出聲波以評估肝組織的硬度，從而可以早期診斷纖維化和疤痕等病症。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 - 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治以及感染疾病和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球肝病診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球肝病診斷市場：成長率分析
  • 全球肝病診斷市場表現：規模與成長，2019-2024
  • 全球肝病診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球肝病診斷總目標市場（TAM）

第6章市場區隔

  • 全球肝病診斷市場（依診斷技術、績效及預測）：2019-2024 年、2024-2029 年、2034 年
  • 實驗室測試
  • 影像學診斷
  • 內視鏡檢查
  • 切片檢查
  • 其他診斷技術
  • 全球肝病診斷市場：依疾病、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 非酒精性脂肪肝
  • 非酒精性脂肪肝
  • 纖維化
  • 肝硬化
  • 肝細胞癌
  • 其他疾病
  • 全球肝病診斷市場（按最終用戶、績效和預測）2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 研究所
  • 其他最終用戶
  • 全球肝病診斷市場，依臨床檢驗類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血液檢查（肝功能檢查、肝炎檢查）
  • 酵素測試（ALT、AST、ALP）
  • 基因檢測
  • 血清學檢測
  • 全球肝病診斷市場、影像細分市場、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 超音波影像
  • 電腦斷層掃描
  • MRI
  • 彈性成像（FibroScan）
  • 全球肝病診斷市場按內視鏡類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 食道胃十二指腸鏡檢查（EGD）
  • 膠囊內視鏡檢查
  • 全球肝病診斷市場，依切片檢查類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 切片檢查（針吸切片）
  • 細針穿刺切片檢查
  • 腹腔鏡切片檢查
  • 全球肝病診斷市場，依其他診斷技術類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分子影像
  • 生物標記檢測
  • 纖維化評分系統

第7章 區域和國家分析

  • 全球肝病診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球肝病診斷市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 肝病診斷市場：競爭格局
  • 肝病診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Echosens SA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • bioMerieux SA
  • Genentech Inc.
  • Perspectum Diagnostics Ltd.
  • Owlstone Medical Ltd.
  • Enterome SA
  • Atlentis Therapeutics AG
  • 89bio Inc.
  • Aligos Therapeutics Inc.
  • BioPredictive SAS
  • Cosara Diagnostics Pvt. Ltd.
  • Hepion Pharmaceuticals Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年肝病診斷市場：提供新機會的國家
  • 2029年肝病診斷市場：細分市場帶來新機會
  • 2029年肝病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33792

Liver disease diagnostics encompass the medical procedures and tests used to detect and evaluate a range of liver conditions, such as liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods typically include blood tests to measure liver enzyme levels, imaging techniques such as ultrasound or CT scans, and occasionally biopsy procedures to collect tissue samples.

The primary diagnostic techniques for liver disease include laboratory tests, imaging, endoscopy, biopsy, and other methods. Laboratory tests involve analyzing blood and other samples to identify liver conditions. These tests are used to diagnose diseases such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, fibrosis, cirrhosis, hepatocellular carcinoma, and more. They are utilized by a variety of end users, including hospitals, laboratories, and other healthcare settings.

The liver disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides liver disease diagnostics market statistics, including liver disease diagnostics industry global market size, regional shares, competitors with a liver disease diagnostics market share, detailed liver disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the liver disease diagnostics industry. This liver disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liver disease diagnostics market size has grown strongly in recent years. It will grow from $36.26 billion in 2024 to $39.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be attributed to factors such as the rising prevalence of both acute and chronic liver conditions, an increase in liver diseases, higher alcohol consumption, growing awareness of liver health, and the expansion of healthcare infrastructure.

The liver disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $52.04 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period is driven by factors including the increasing geriatric population, higher spending on research and development, a rise in the number of biopsy procedures and related diseases, and the broader adoption of telemedicine. Key trends expected during this period include the rise of personalized medicine, technological advancements in diagnostic kits, innovations in rapid testing, progress in healthcare technologies, and improvements in diagnostic methods.

The rise in alcohol consumption is expected to drive the growth of the liver disease diagnostics market. Alcohol consumption has increased due to changing social norms, greater affordability, widespread availability, and rising stress or mental health challenges. As alcohol consumption impacts liver health, diagnostic tools are essential for detecting early signs of liver damage, such as fatty liver, hepatitis, or cirrhosis. For example, according to the National Health Service (NHS) in December 2022, alcohol consumption rose with age, with 62% of individuals aged 16 to 24 reporting consumption in the past 12 months, and 85% of individuals aged 55 to 74 engaging in alcohol consumption. This trend is contributing to the growth of the liver disease diagnostics market, as there is a greater need for early detection and monitoring of liver health.

Companies in the liver disease diagnostics market are focusing on the development of innovative, non-invasive tools to assess liver conditions. These tools provide accurate and efficient diagnostic methods without the need for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool aimed at the early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). FibroScan uses elastography technology to measure liver stiffness and fat content quickly and accurately, offering a non-invasive alternative to traditional biopsies. The procedure takes only 5 to 15 minutes and involves placing a probe over the liver, which emits sound waves to assess liver tissue stiffness, enabling early diagnosis of conditions such as fibrosis or scarring.

In August 2024, Quest Diagnostics, a US-based medical laboratory company, acquired LifeLabs for $1 billion. This acquisition is expected to significantly enhance Quest Diagnostics' operational capabilities and expand its healthcare services in Canada. LifeLabs, a Canada-based laboratory company, specializes in liver disease diagnostics, particularly focusing on conditions such as non-alcoholic fatty liver disease (NAFLD), and the acquisition will help broaden Quest's diagnostic offerings in this area.

Major players in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMerieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, and Aiforia Technologies Plc.

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver disease diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liver disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liver disease diagnostics market consists of revenues earned by entities by providing services such as liver disease diagnostics, imaging studies, fibrosis assessment, viral hepatitis screening, and alcohol-related liver disease evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver disease diagnostics market also includes sales of blood test kits, imaging devices, and biopsy needles and instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques
  • 2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases
  • 3) By End Users: Hospitals; Laboratories; Other End Users
  • Subsegments:
  • 1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests
  • 2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)
  • 3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy
  • 4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy
  • 5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Fujifilm Holdings Corporation; Echosens SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liver Disease Diagnostics Market Characteristics

3. Liver Disease Diagnostics Market Trends And Strategies

4. Liver Disease Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Liver Disease Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Liver Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Liver Disease Diagnostics Market Growth Rate Analysis
  • 5.4. Global Liver Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Liver Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Liver Disease Diagnostics Total Addressable Market (TAM)

6. Liver Disease Diagnostics Market Segmentation

  • 6.1. Global Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Other Diagnosis Techniques
  • 6.2. Global Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Steatohepatitis
  • Fibrosis
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Other Diseases
  • 6.3. Global Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Laboratories
  • Other End Users
  • 6.4. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests (Liver Function Tests, Hepatitis Panel)
  • Enzyme Tests (ALT, AST, ALP)
  • Genetic Testing
  • Serological Tests
  • 6.5. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound Imaging
  • CT Scans
  • MRI
  • Elastography (FibroScan)
  • 6.6. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Esophagogastroduodenoscopy (EGD)
  • Capsule Endoscopy
  • 6.7. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Biopsy (Needle Biopsy)
  • Fine Needle Aspiration Biopsy
  • Laparoscopic Biopsy
  • 6.8. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Other Diagnosis Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Imaging
  • Biomarker Testing
  • Fibrosis Scoring Systems

7. Liver Disease Diagnostics Market Regional And Country Analysis

  • 7.1. Global Liver Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Liver Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Disease Diagnostics Market

  • 8.1. Asia-Pacific Liver Disease Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Disease Diagnostics Market

  • 9.1. China Liver Disease Diagnostics Market Overview
  • 9.2. China Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Disease Diagnostics Market

  • 10.1. India Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Disease Diagnostics Market

  • 11.1. Japan Liver Disease Diagnostics Market Overview
  • 11.2. Japan Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Disease Diagnostics Market

  • 12.1. Australia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Disease Diagnostics Market

  • 13.1. Indonesia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Disease Diagnostics Market

  • 14.1. South Korea Liver Disease Diagnostics Market Overview
  • 14.2. South Korea Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Disease Diagnostics Market

  • 15.1. Western Europe Liver Disease Diagnostics Market Overview
  • 15.2. Western Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Disease Diagnostics Market

  • 16.1. UK Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Disease Diagnostics Market

  • 17.1. Germany Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Disease Diagnostics Market

  • 18.1. France Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Disease Diagnostics Market

  • 19.1. Italy Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Disease Diagnostics Market

  • 20.1. Spain Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Disease Diagnostics Market

  • 21.1. Eastern Europe Liver Disease Diagnostics Market Overview
  • 21.2. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Disease Diagnostics Market

  • 22.1. Russia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Disease Diagnostics Market

  • 23.1. North America Liver Disease Diagnostics Market Overview
  • 23.2. North America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Disease Diagnostics Market

  • 24.1. USA Liver Disease Diagnostics Market Overview
  • 24.2. USA Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Disease Diagnostics Market

  • 25.1. Canada Liver Disease Diagnostics Market Overview
  • 25.2. Canada Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Disease Diagnostics Market

  • 26.1. South America Liver Disease Diagnostics Market Overview
  • 26.2. South America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Disease Diagnostics Market

  • 27.1. Brazil Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Disease Diagnostics Market

  • 28.1. Middle East Liver Disease Diagnostics Market Overview
  • 28.2. Middle East Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Disease Diagnostics Market

  • 29.1. Africa Liver Disease Diagnostics Market Overview
  • 29.2. Africa Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Disease Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Liver Disease Diagnostics Market Competitive Landscape
  • 30.2. Liver Disease Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Echosens SA Overview, Products and Services, Strategy and Financial Analysis

31. Liver Disease Diagnostics Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Laboratory Corporation of America Holdings
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Siemens Healthineers AG
  • 31.5. bioMerieux SA
  • 31.6. Genentech Inc.
  • 31.7. Perspectum Diagnostics Ltd.
  • 31.8. Owlstone Medical Ltd.
  • 31.9. Enterome SA
  • 31.10. Atlentis Therapeutics AG
  • 31.11. 89bio Inc.
  • 31.12. Aligos Therapeutics Inc.
  • 31.13. BioPredictive SAS
  • 31.14. Cosara Diagnostics Pvt. Ltd.
  • 31.15. Hepion Pharmaceuticals Inc.

32. Global Liver Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Disease Diagnostics Market

34. Recent Developments In The Liver Disease Diagnostics Market

35. Liver Disease Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Liver Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Liver Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Liver Disease Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer